Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 33 clinical trials
featured
A Randomized, Multicenter, Double-Blind, Flexibly-dosed, Efficacy and Safety Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

The primary objective of this study is to assess the safety and efficacy of escitalopram relative to placebo in the acute treatment of children (aged 7 through 11 years) and

  • 65 views
  • 23 Nov, 2020
  • 1 location
featured
Adolescents with Depression and/or Anxiety and a Parent or Sibling with Bipolar Disorder

Adolescents with Depression and/or Anxiety and a Parent or Sibling with Bipolar Disorder

  • 1594 views
  • 25 Mar, 2021
  • 1 location
A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression

The primary objective of this multicenter study is to evaluate the efficacy of escitalopram in treatment resistant depression (TRD), assessed by 2 consecutive failed antidepressant

venlafaxine
antidepressants
depression
major depressive disorder
citalopram
  • 24 views
  • 07 Nov, 2020
  • 2 locations
Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy

Escitalopram with cognitive-behavior therapy in alleviating the symptoms of the marijuana withdrawal syndrome in regular chronic users of marijuana. We predict that combined pharmacological treatment

escitalopram
withdrawal symptoms
cannabis withdrawal
  • 14 views
  • 07 Nov, 2020
  • 1 location
Serotonergic Modulation of Cognition Emotion and Brain Activation in Healthy Volunteers

>To investigate how sub-chronic administration of 20 mg of escitalopram affects cognitive performance ('cold' cognition) and social-emotional functioning ('hot' cognition) compared with placebo; and

  • 52 views
  • 22 Sep, 2021
  • 1 location
Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS).

antidepressant drug (Escitalopram) in treating mild-to-moderate depression, to evaluate the depressive subtypes who are suitable for the TECAS treatment. To achieve this objective, 470 patients with mild-to

  • 0 views
  • 23 Jan, 2021
  • 6 locations
Treatment Youth With Obsessive-Compulsive Disorder

activity are affected in OCD. The second aim is to investigate the effects of a specific psychotropic medication (escitalopram) on high cognitive processes and brain activity in OCD. We will

citalopram
anxiety
psychotropic drugs
  • 139 views
  • 07 Nov, 2020
  • 1 location
Escitalopram and Language Intervention for Subacute Aphasia

In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by

  • 0 views
  • 16 Sep, 2021
  • 3 locations
A Study Utilizing Escitalopram in Glioma Patients

This pilot study will include grade IV glioma patients treated with SSRIs during approximately a 17 week study period. Changes in cognition and evaluation of psychosocial factors from baseline to after 17 weeks of treatment with SSRI study drug will be calculated.

  • 0 views
  • 13 Aug, 2021
  • 1 location
Escitalopram for Agitation in Alzheimer's Disease

The purpose of this study is to evaluate the safety and efficacy of escitalopram for agitation in Alzheimer's dementia.

mental state examination
citalopram
cognitive disorder
agitation
alzheimer's disease
  • 282 views
  • 15 May, 2021
  • 33 locations